Rationally Minimizing Natural Product Libraries Using Mass Spectrometry

Monica Ness,Thilini Peramuna,Karen L Wendt,Jennifer E Collins,Jarrod B King,Raphaella Paes,Natalia Mojica Santos,Crystal Okeke,Cameron R Miller,Debopam Chakrabarti,Robert H Cichewicz,Laura-Isobel McCall
DOI: https://doi.org/10.1101/2024.05.22.595232
2024-05-26
Abstract:Natural product libraries are crucial to drug development, but large libraries drastically increase the time and cost during initial high throughput screens. Here, we developed a method that leverages liquid chromatography-tandem mass spectrometry spectral similarity to dramatically reduce library size, with minimal bioactive loss. This method offers a broadly applicable strategy for accelerated drug discovery with cost reductions, which enable implementation in resource-limited settings.
Bioinformatics
What problem does this paper attempt to address?
This paper mainly explores how to reduce the size of natural product libraries rationally through mass spectrometry technology to improve the efficiency and reduce the cost of drug discovery. In the study, the authors developed a method of using liquid chromatography-tandem mass spectrometry (LC-MS/MS) spectral similarity to select extracts, which can significantly reduce the size of the library while retaining the diversity of biologically active molecules. The large-scale natural product library in traditional methods increases the time and cost of high-throughput screening, and may lead to duplicate discoveries. The new strategy proposed in the paper focuses on preserving the diversity of skeletons, as molecules with similar structures often have similar biological activities. By comparing the MS/MS spectral similarity in the molecular network, the authors constructed a rationalized library and selected extracts with the most unique skeletons, thereby accelerating the accumulation of diversity. In tests on several different biologically active targets, the library constructed by this method significantly reduced the size while maintaining or improving the hit rate of biological activity. For example, compared to random selection, the new method can achieve the same level of skeleton diversity with fewer extracts. In addition, the study also showed that this method can preserve key molecules related to biological activity, reducing the loss of active compounds. In summary, the paper addresses the problem of effectively reducing the size of natural product libraries in the early stages of drug discovery while maintaining the diversity of biologically active compounds and discovery efficiency. This is particularly valuable in resource-limited environments.